A novel minicircle vector based system for inhibting the replication and gene expression of Enterovirus 71 and Coxsackievirus A16

Antiviral Research

Volumn 96, Issue 2, 2012, Pages 234-244

  Yang, Zhuo ^a   Li, Guodong ^a   Zhang, Yingqiu ^a   Liu, Xiaoman ^a   Tien, Po ^a  

^a INSTITUTE OF MICROBIOLOGY   (China)

Author keywords

Antiviral therapy; Coxsackievirus A16; Enterovirus 71; Minicircle vector; RNA interference

Indexed keywords

MINICIRCLE VECTOR; SMALL INTERFERING RNA; UNCLASSIFIED DRUG; VIRUS PROTEIN; VIRUS RNA; VIRUS VECTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHINA; CONTROLLED STUDY; COXSACKIE VIRUS A; COXSACKIE VIRUS A16; CYTOTOXICITY; ENTEROVIRUS 71; GENE EXPRESSION; GENE SILENCING; HAND FOOT AND MOUTH DISEASE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROGENY; RHABDOMYOSARCOMA; RNA INTERFERENCE; VIRAL GENE DELIVERY SYSTEM; VIRUS REPLICATION; VIRUS STRAIN;

ANIMALS; BIOLOGICAL AGENTS; CELL LINE; DISEASE MODELS, ANIMAL; ENTEROVIRUS; ENTEROVIRUS A, HUMAN; GENE EXPRESSION REGULATION, VIRAL; GENE PRODUCTS, POL; GENE SILENCING; GENETIC VECTORS; HAND, FOOT AND MOUTH DISEASE; HUMANS; MICE; PEPTIDE HYDROLASES; RNA, SMALL INTERFERING; TREATMENT OUTCOME; VIRUS REPLICATION;

COXSACKIEVIRUS; HUMAN ENTEROVIRUS 71; MUS;

EID: 84867414991     PISSN: 01663542     EISSN: 18729096     Source Type: Journal    
DOI: 10.1016/j.antiviral.2012.08.003     Document Type: Article

References (44)

1. Alexander J.P., Baden L., Pallansch M.A., Anderson L.J. Enterovirus 71 infections and neurologic disease-United States, 1977-1991. J. Infect. Dis. 1994, 169:905-908.
2. Bible J.M., Iturriza-Gomara M., Megson B., Brown D., Pantelidis P., Earl P., Bendig J., Tong C.Y. Molecular epidemiology of human enterovirus 71 in the United Kingdom from 1998 to 2006. J. Clin. Microbiol. 2008, 46:3192-3200.
3. Bigger B.W., Tolmachov O., Collombet J.M., Fragkos M., Palaszewski I., Coutelle C. An araC-controlled bacterial cre expression system to produce DNA minicircle vectors for nuclear and mitochondrial gene therapy. J. Biol. Chem. 2001, 276:23018-23027.
4. Bitko V., Musiyenko A., Shulyayeva O., Barik S. Inhibition of respiratory viruses by nasally administered siRNA. Nat. Med. 2005, 11:50-55.
5. Chan K.P., Goh K.T., Chong C.Y., Teo E.S., Lau G., Ling A.E. Epidemic hand, foot and mouth disease caused by human enterovirus 71, Singapore. Emerg. Infect. Dis. 2003, 9:78-85.
6. Chen Z.Y., He C.Y., Ehrhardt A., Kay M.A. Minicircle DNA vectors devoid of bacterial DNA result in persistent and high-level transgene expression in vivo. Mol. Ther. 2003, 8:495-500.
7. Chen Z.Y., He C.Y., Meuse L., Kay M.A. Silencing of episomal transgene expression by plasmid bacterial DNA elements, in vivo. Gene Ther. 2004, 11:856-864.
8. Chen K.T., Chang H.L., Wang S.T., Cheng Y.T., Yang J.Y. Epidemiologic features of hand-foot-mouth disease and herpangina caused by enterovirus 71 in Taiwan, 1998-2005. Pediatrics 2007, 120:244-252.
9. Darquet A.M., Cameron B., Wils P., Scherman D., Crouzet J. A new DNA vehicle for nonviral gene delivery: supercoiledminicircle. Gene Ther. 1997, 4:1341-1349.
10. Darquet A.M., Rangara R., Kreiss P., Schwartz B., Naimi S., Delaère P., Crouzet J., Scherman D. Minicircle: an improved DNA molecule for in vitro and in vivo gene transfer. Gene Ther. 1999, 6:209-218.
11. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., Mello C.C. Potent and specific genetic interference by double-stranded RNA in Caenorhabditis elegans. Nature 1998, 391:806-811.
12. Gao Y.Z., Sun L., Dong J., Xu X.Y., Shu Y.L., Chen M.H., Yin L., Liang Z.C., Jin Q. Rapid identification of small interfering RNA that can effectively inhibit the replication of multiple influenza B virus strains. Antivir. Ther. 2006, 11:431-438.
13. Giladi H., Ketzinel-Gilad M., Rivkin L., Felig Y., Nussbaum O., Galun E. Small interfering RNA inhibits hepatitis B virus replication in mice. Mol. Ther. 2003, 8:769-776.
14. Gilbert G.L., Dickson K.E., Waters M.J., Kennett M.L., Land S.A., Sneddon M. Outbreak of enterovirus 71 infection in Victoria, Australia, with a high incidence of neurologic involvement. Pediatr. Infect. Dis. J. 1988, 7:484-488.
15. Gitlin L., Karelsky S., Andino R. Short interfering RNA confers intracellular antiviral immunity in human cells. Nature 2002, 418:430-434.
16. Haasnoot J., Westerhout E.M., Berkhout B. RNA interference against viruses: strike and counterstrike. Nat. Biotechnol. 2007, 25:1435-1443.
17. Ho M., Chen E.R., Hsu K.H., Twu S.J., Chen K.T., Tsai S.F., Wang J.R., Shih S.R. An epidemic of enterovirus 71 infection in Taiwan. Taiwan Enterovirus Epidemic Working Group. N. Engl. J. Med. 1999, 341:929-935.
18. Ishimaru Y., Nakano S., Yamaoka K., Takami S. Outbreaks of hand, foot, and mouth disease by enterovirus 71. High incidence of complication disorders of central nervous system. Arch. Dis. Child. 1980, 55:583-588.
19. Jacque J.M., Triques K., Stevenson M. Modulation of HIV-1 replication by RNA interference. Nature 2002, 418:435-438.
20. Jechlinger W. Optimization and delivery of plasmid DNA for vaccination. Exp. Rev. Vaccin. 2006, 5:803-825.
21. Li Y., Wasser S., Lim S.G., Tan T.M. Genome-wide expression profiling of RNA interference of hepatitis B virus gene expression and replication. Cell. Mol. Life Sci. 2004, 61:2113-2124.
22. Liu Y.P., Haasnoot J., Berkhout B. Design of extended short hairpin RNAs for HIV-1 inhibition. Nucleic Acids Res. 2007, 35:5683-5693.
23. Lu W.W., Hsu Y.Y., Yang J.Y., Kung S.H. Selective inhibition of enterovirus 71 replication by short hairpin RNAs. Biochem. Biophys. Res. Commun. 2004, 325:494-499.
24. Lyon A.R., Sato M., Hajjar R.J., Samulski R.J., Harding S.E. Gene therapy: targeting the myocardium. Heart 2008, 94:89-99.
25. Marshall E. Gene therapy death prompts review of adenovirus vector. Science 1999, 286:2244-2245.
26. Phipps K.M., Martinez A., Lu J., Heinz B.A., Zhao G.S. Small interfering RNA molecules as potential anti-human rhinovirus agents: in vitro potency, specificity, and mechanism. Antiviral Res. 2004, 61:49-55.
27. Qiu J. Enterovirus 71 infection: a new threat to global public health?. Lancet Neurol. 2008, 7:868-869.
28. Racaniello V.R. Picornaviridae: the viruses and their replication. Fields Virology 2007, 796-839. Lippincott Williams & Wilkins, Philadelphia, PA. fifth ed. D.M. Knipe (Ed.).
29. Robinson C.R., Doane F.W., Rhodes A.J. Report of an outbreak of febrile illness with pharyngeal lesions and exanthem: Toronto, summer 1957: isolation of group A Coxsackie virus. Can. Med. Assoc. J. 1958, 79:615-621.
30. Shinohara M., Uchida K., Shimada S., Segawa Y., Hoshino Y. Characterization of enterovirus type 71 isolated in Saitama Prefecture in 2000. Kansenshogaku Zasshi 2001, 75:490-494.
31. Sim A.C., Luhur A., Tan T.M., Chow V.T., Poh C.L. RNA interference against enterovirus 71 infection. Virology 2005, 341:72-79.
32. Solomon T., Lewthwaite P., Perera D., Cardoso M.J., McMinn P., Ooi M.H. Virology, epidemiology, pathogenesis, and control of enterovirus 71. Lancet Infect. Dis. 2010, 10:778-790.
33. Tan E.L., Tan T.M.C., Chow V.T.K., Poh C.L. Enhanced potency and efficacy of 29-mer shRNAs in inhibition of Enterovirus 71. Antiviral Res. 2007, 74:9-15.
34. Wang C.Y., Li Lu F., Wu M.H., Lee C.Y., Huang L.M. Fatal coxsackievirus A16 infection. Pediatr. Infect. Dis. J. 2004, 23:275-276.
35. Wong K.T., Munisamy B., Ong K.C., Kojima H., Noriyo N., Chua K.B., Ong B.B., Nagashima K. The distribution of inflammation and virus in human enterovirus 71 encephalomyelitis suggests possible viral spread by neural pathways. J. Neuropathol. Exp. Neurol. 2008, 67:162-169.
36. Wright H.T., Landing B.H., Lennette E.H., Mcallister R.M. Fatal infection in an infant associated with Coxsackie virus group A, type 16. N. Engl. J. Med. 1963, 268:1041-1044.
37. Wu Z.Q., Gao Y.Z., Sun L.L., Tien P., Jin Q. Quick identification of effective small interfering RNAs that inhibit the replication of coxsackievirus A16. Antiviral Res. 2008, 80:295-301.
38. Wu Z.Q., Yang F., Zhao R., Zhao L.N., Guo D.Y., Jin Q. Identification of small interfering RNAs which inhibit the replication of several Enterovirus 71 strains in China. J. Virol. Methods 2009, 159:233-238.
39. Yip C.C., Lau S.K., Zhou B., Zhang M.X., Tsoi H.W., Chan K.H., Chen X.C., Woo P.C., Yuen K.Y. Emergence of enterovirus 71 " double-recombinant" strains belonging to a novel genotype D originating from southern China: first evidence for combination of intratypic and intertypic recombination events in EV 71. Arch. Virol. 2010, 155:1413-1424.
40. Yokota T., Sakamoto N., Enomoto N., Tanabe Y., Miyagishi M., Maekawa S., Yi L., Kurosaki M., Taira K., Watanabe M., Mizusawa H. Inhibition of intracellular hepatitis C virus replication by synthetic and vector-derived small interfering RNAs. EMBO Rep. 2003, 4:602-608.
41. Yuan J., Cheung P.K., Zhang H.M., Chau D., Yang D. Inhibition of coxsackievirus B3 replication by small interfering RNAs requires perfect sequence match in the central region of the viral positive strand. J. Virol. 2005, 79:2151-2159.
42. Zhang D., Lu J. Enterovirus 71 vaccine: close but still far. Int. J. Infect. Dis. 2010, 14:739-743.
43. Zhang Y., Wang D., Yan D., Zhu S., Liu J., Wang H., Zhao S., Yu D., Nan L., An J., Chen L., An H., Xu A., Xu W. Molecular evidence of persistent epidemic and evolution of subgenotype B1 coxsackievirus A16-associated hand, foot, and mouth disease in China. J. Clin. Microbiol. 2010, 48:619-622.
44. Zhou H., Jin M., Yu Z., Xu X., Peng Y., Wu H., Liu J., Liu H., Cao S., Chen H. Effective small interfering RNAs targeting matrix and nucleocapsid protein gene inhibit influenza A virus replication in cells and mice. Antiviral Res. 2007, 76:186-193.